Idramantone

Idramantone
Clinical data
Other names	Kemantane; Kemantan; 5-Hydroxyadamantanone; 4-Oxo-1-adamantanol; 4-Oxoadamantan-1-ol; 1-Hydroxy-4-ketoadamantane
Identifiers
	IUPAC name 5-hydroxyadamantan-2-one;
CAS Number	20098-14-0;
PubChem CID	64184;
ChemSpider	57758;
UNII	7J4759Y5J1;
ChEBI	CHEBI:48581;
ChEMBL	ChEMBL2105062;
CompTox Dashboard (EPA)	DTXSID8046581 ;
Chemical and physical data
Formula	C10H14O2
Molar mass	166.220 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1C2CC3CC(C2)(CC1C3=O)O;
	InChI InChI=1S/C10H14O2/c11-9-7-1-6-2-8(9)5-10(12,3-6)4-7/h6-8,12H,1-5H2; Key:TZBDEVBNMSLVKT-UHFFFAOYSA-N;

Idramantone, also known as kemantane or as 5-hydroxyadamantan-2-one, is an experimental immunostimulant of the adamantane group that was never marketed.^[1]^[2] It is described as a lymphocyte and antibody stimulant in mice and as a T-cell suppressor.^[1]^[2] The drug was first described by 1968.^[1]

References

1 2 3 Buckingham J, Macdonald F (1996). Dictionary of Organic Compounds (Sixth, Supplement 1 ed.). Taylor & Francis. p. 152. ISBN 978-0-412-54110-0. Retrieved 13 September 2024.
1 2 Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 145. ISBN 978-94-011-4439-1. Retrieved 13 September 2024.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by adding missing information.

[BuckinghamMacdonald1996-1] 1 2 3 Buckingham J, Macdonald F (1996). Dictionary of Organic Compounds (Sixth, Supplement 1 ed.). Taylor & Francis. p. 152. ISBN 978-0-412-54110-0. Retrieved 13 September 2024.

[MortonHall2012-2] 1 2 Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 145. ISBN 978-94-011-4439-1. Retrieved 13 September 2024.

[1]

[2]

This page was redesigned at the edge.

References